Clinical Study
Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A
Table 2
Comparison of DLQI and the severity of hyperhidrosis across sex, before and after treatment with BTX-A.
| | | Male | Female | value |
| | Total score of DLQI before treatment with BTX-A (median (25th–75th percentiles))* | 18.8 (17.7, 19.9) | 21 (19.9, 22.1) | 0.015 | | Total score of DLQI after treatment with BTX-A (mean (95% CI))* | 3.2 (2.9, 3.6) | 3.1 (2.7, 3.5) | 0.489 | | The severity of hyperhidrosis before treatment with BTX-A ( (%))* | | | | | 1 | 1 (1.9%) | — | 0.001 | | 2 | 9 (17.3%) | 2 (3%) | | 3 | 17 (32.7%) | 14 (20.9%) | | 4 | 25 (48.1%) | 51 (76.1%) | | The severity of hyperhidrosis after treatment with BTX-A ( (%))* | | | | | 1 | 38 (73.1%) | 39 (58.2%) | 0.079 | | 2 | 14 (26.9%) | 26 (38.3%) | | 3 | — | 2 (3%) |
|
|
Mann-Whitney test.
|
